251 related articles for article (PubMed ID: 5350098)
41. [The thrombolytic medications].
Rignault D
Presse Med (1893); 1969 Jan; 77(2):55-8. PubMed ID: 4239477
[No Abstract] [Full Text] [Related]
42. Thrombolytic drugs: quo vadis?
Verstraete M
Acta Clin Belg; 1977; 32(6):434-9. PubMed ID: 616754
[No Abstract] [Full Text] [Related]
43. [Thrombolytic treatment (theoretical basis, therapeutic protocols, monitoring)].
Conard J; Samama M
Ann Anesthesiol Fr; 1978; 19(8):711-9. PubMed ID: 31115
[TBL] [Abstract][Full Text] [Related]
44. Fibrinolytic therapy.
Klatte EC; Becker GJ; Holden RE; Yune HY
Radiology; 1986 Jun; 159(3):619-24. PubMed ID: 3704143
[TBL] [Abstract][Full Text] [Related]
45. Thrombolytic therapy.
Brody RJ; Sharma GV
Compr Ther; 1989 Apr; 15(4):63-70. PubMed ID: 2495885
[No Abstract] [Full Text] [Related]
46. Thrombolytic therapy: overview of results in major vascular occlusions.
Marder VJ
Thromb Haemost; 1995 Jul; 74(1):101-5. PubMed ID: 8578440
[TBL] [Abstract][Full Text] [Related]
47. Thrombolytic therapy in stroke: possibilities and hazards.
Del Zoppo GJ; Zeumer H; Harker LA
Stroke; 1986; 17(4):595-607. PubMed ID: 3526644
[No Abstract] [Full Text] [Related]
48. Therapeutic use of thrombolytic agents.
Stambaugh RL; Alexander MR
Am J Hosp Pharm; 1981 Jun; 38(6):817-24. PubMed ID: 7018230
[TBL] [Abstract][Full Text] [Related]
49. [Indications for thrombolytic agents in venous thrombosis and pulmonary embolism].
Serradimigni A; Romani A; Chiche G; Aubry J; Philip F
Rev Prat; 1981 Nov; 31(53):3793-4 passim. PubMed ID: 7313474
[No Abstract] [Full Text] [Related]
50. Advances in thrombolytic therapy.
Rutkowski DM; Burkle WS
Drug Intell Clin Pharm; 1982 Feb; 16(2):115-21. PubMed ID: 7042263
[TBL] [Abstract][Full Text] [Related]
51. Thrombolytic therapy: current status (2).
Marder VJ; Sherry S
N Engl J Med; 1988 Jun; 318(24):1585-95. PubMed ID: 3287158
[No Abstract] [Full Text] [Related]
52. [When is fibrinolytic therapy indicated?].
Woitinas F
Med Klin; 1980 Feb; 75(3):98-107. PubMed ID: 6990218
[No Abstract] [Full Text] [Related]
53. [Experience with the clinical use of fibrinolysin].
Panchenko VM
Vrach Delo; 1966 Nov; 11():8-11. PubMed ID: 4237274
[No Abstract] [Full Text] [Related]
54. [Thrombolytic treatment].
Léonetti J; Mathieu P; Bory M; Djiane P; Mostefa-Kara S; Egré A; Serradimigni A
Rev Prat; 1977 Dec; 27(57):4009-17. PubMed ID: 345401
[No Abstract] [Full Text] [Related]
55. Further experience with "minidosage" in fibrinolytic treatment.
Heikinheimo R; Ruosteenoja R
Curr Ther Res Clin Exp; 1971 Jul; 13(7):444-50. PubMed ID: 5000297
[No Abstract] [Full Text] [Related]
56. Thrombosis: the relationship of hemostatic mechanisms to drug therapy.
Wessler S; Gitel SN
J Neurosurg; 1981 Jan; 54(1):1-11. PubMed ID: 7007586
[TBL] [Abstract][Full Text] [Related]
57. [The thrombolysis therapy, its application and dosage. II. Indications and practical application].
Bosseckert H
Z Arztl Fortbild (Jena); 1966 Jul; 60(14):841-7. PubMed ID: 5994170
[No Abstract] [Full Text] [Related]
58. [On the efficacy of thrombolytic agents].
Urbaniuk KG
Klin Med (Mosk); 1968 Aug; 46(8):94-7. PubMed ID: 5707111
[No Abstract] [Full Text] [Related]
59. [Coumarin necrosis].
Jost P
Schweiz Med Wochenschr; 1969 Jul; 99(30):1069-77. PubMed ID: 5351141
[No Abstract] [Full Text] [Related]
60. [Fibrinolytic treatment of cerebral thromboembolism].
Castellano F; Ambrosio A; Profeta G
Neurochirurgie; 1970; 16(1):81-8. PubMed ID: 5446716
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
